# On-treatment Biomarkers in Metastatic Colorectal Cancer for Life

> **NCT05755672** · — · RECRUITING · sponsor: **Region Skane** · enrollment: 100 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer
- Chemotherapy Effect
- Peritoneal Metastases
- Liver Metastasis Colon Cancer
- Lung Metastases

## Interventions

- **DRUG:** Chemotherapy
- **PROCEDURE:** Resection of the primary tumor
- **PROCEDURE:** Resection of tumour metastases
- **PROCEDURE:** Blood sampling during chemotherapy

## Key facts

- **NCT ID:** NCT05755672
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-01
- **Primary completion:** 2026-12
- **Final completion:** 2033-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755672, "On-treatment Biomarkers in Metastatic Colorectal Cancer for Life". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05755672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*